Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

A Study of CTD402 in T-ALL/LBL Patients

NCT07070219

Conditions
Acute Lymphocytic Leukemia Refractory, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma

NCT07114367

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Catholic univ of Yeouido St Mary's Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Recruiting

Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients

NCT05300282

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS Candiolo, Turin, Italy
  • S.C. Ematologia e Trapianto emopoietico - Azienda Ospedaliera S.Giuseppe Moscati Avellino, Italy
  • Divisione di Oncologia e dei Tumori immuto-correlati - IRCCS Centro di Riferimento Oncologico di Aviano Aviano, Italy
View all 32 locations
View Trial Details
Recruiting

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

NCT05634369

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +3 more
Locations
  • University of Alabama South Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
View all 22 locations
View Trial Details
Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
Locations
  • Helios Clinical Research Cerritos, California, United States
  • California Research Institute Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 102 locations
View Trial Details
Recruiting

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

NCT06208657

Conditions
Central Nervous System Neoplasms, Childhood Brain Tumor, Childhood Cancer, +18 more
Locations
  • John Hunter Children's Hospital Newcastle, New South Wales, Australia
  • Sydney Children's Hospital, Randwick Sydney, New South Wales, Australia
  • The Children's Hospital at Westmead Sydney, New South Wales, Australia
  • Queensland Children's Hospital Brisbane, Queensland, Australia
View all 14 locations
View Trial Details

Related conditions